The group’s principle activity is to develop pharmaceutical products. The products of the group include Ceplene and Azixa. The group products sold under the trade name Neurontin(R), Lidoderm(R) and Lyrica(R). In January 2006, the group acquired Maxim Pharmaceuticals, Inc. The group operates from the United States and Germany.
